ATRYS HEALTH SA


Type of ratings: Corporate

Rating value: BB

Outlook: Stable

License: EthiFinance Ratings

Solicited

EthiFinance Ratings affirms Atrys Group s "BB" rating, maintaining its Stable outlook. Atrys focuses its business on the health sector, ranging from the prevention of occupational risks to the integrated management of oncological disease (diagnosis and radiotherapy/immunotherapy). Currently, the group is in an expansion and consolidation through and outstanding inorganic and organic growth. In 2021, the group had (proforma and adjusted figures) a turnover of € 165.3MM and EBITDA of € 37MM (margin of 22.4%), also showing a NFD/EBITDA ratio of 4.8x. The group capitalization figure stood at € 456MM in 2022.

Ratings

Rating action: Affirmed

Action date: 2023-03-17

Date last rating: 2023-03-17

Date first rating: 2019-07-08

Documents

Executive summary:

Methodologies

Return to the rating page